Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
Glioblastoma (GBM) is known as a tumor type, which arises from astrocytes. Several studies
indicated that GBM tumor cells are malignant. This is because of the fact that they consist of …
indicated that GBM tumor cells are malignant. This is because of the fact that they consist of …
MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
A Shea, V Harish, Z Afzal, J Chijioke, H Kedir… - Cancer …, 2016 - Wiley Online Library
Glioblastoma multiforme (GBM) is the most common and lethal cancer of the adult brain,
remaining incurable with a median survival time of only 15 months. In an effort to identify …
remaining incurable with a median survival time of only 15 months. In an effort to identify …
A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma
Q Wang, J Zhang, Y Liu, W Zhang, J Zhou, R Duan… - Cancer letters, 2016 - Elsevier
The comprehensive lncRNA expression signature in glioma has not yet been fully
elucidated. We performed a high-throughput microarray to detect the ncRNA expression …
elucidated. We performed a high-throughput microarray to detect the ncRNA expression …
Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression
S Yan, Z Tang, K Chen, Y Liu, G Yu, Q Chen… - Journal of Experimental …, 2018 - Springer
Background Emerging evidences have indicated that long noncoding RNAs (lncRNAs) play
essential roles in the development and progression of cancers. Dysregulation of lncRNA …
essential roles in the development and progression of cancers. Dysregulation of lncRNA …
microRNA regulation of Wnt signaling pathways in development and disease
JL Song, P Nigam, SS Tektas, E Selva - Cellular signalling, 2015 - Elsevier
Wnt signaling pathways and microRNAs (miRNAs) are critical regulators of development.
Aberrant Wnt signaling pathways and miRNA levels lead to developmental defects and …
Aberrant Wnt signaling pathways and miRNA levels lead to developmental defects and …
Mir-24-3p downregulation contributes to VP16–DDP resistance in small-cell lung cancer by targeting ATG4A
B Pan, Y Chen, H Song, Y Xu, R Wang, L Chen - Oncotarget, 2014 - pmc.ncbi.nlm.nih.gov
Although the combination of etoposide (VP16) and cisplatin (DDP) is widely used as a first-
line treatment for advanced-stage small-cell lung cancer (SCLC), chemoresistance limits its …
line treatment for advanced-stage small-cell lung cancer (SCLC), chemoresistance limits its …
Melatonin targeting non-coding RNAs in cancer: Focus on mechanisms and potential therapeutic targets
A Mafi, A Keshavarzmotamed, N Hedayati… - European journal of …, 2023 - Elsevier
Despite, melatonin is mainly known as a regulatory factor for circadian rhythm, its notable
role in other fundamental biological processes, such as redox homeostasis and …
role in other fundamental biological processes, such as redox homeostasis and …
Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT)
J Li, Q Li, L Lin, R Wang, L Chen, W Du, C Jiang, R Li - BMC neurology, 2018 - Springer
Background Glioma metastasis, invasion, epithelial-mesenchymal transition (EMT) and
chemoresistance indicate poor prognosis. Accumulating evidence reveals that Notch1 is an …
chemoresistance indicate poor prognosis. Accumulating evidence reveals that Notch1 is an …
Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
M Katoh - Frontiers in cell and developmental biology, 2014 - frontiersin.org
Cardiovascular diseases and cancers are the leading causes of morbidity and mortality in
the world. MicroRNAs (miRNAs) are short non-coding RNAs that primarily repress target …
the world. MicroRNAs (miRNAs) are short non-coding RNAs that primarily repress target …
[HTML][HTML] Angioregulatory role of miRNAs and exosomal miRNAs in glioblastoma pathogenesis
B Bouzari, S Mohammadi, DO Bokov… - Biomedicine & …, 2022 - Elsevier
Glioblastoma (GB) is a highly aggressive cancer of the central nervous system, occurring in
the brain or spinal cord. Many factors such as angiogenesis are associated with GB …
the brain or spinal cord. Many factors such as angiogenesis are associated with GB …